Reintroduction of etanercept during treatment of cutaneous Mycobacterium marinum infection in a patient with ankylosing spondylitis

Arthritis Rheum. 2009 May 15;61(5):583-6. doi: 10.1002/art.24095.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antifungal Agents / therapeutic use
  • Antirheumatic Agents / therapeutic use*
  • Candida
  • Candidiasis, Cutaneous / drug therapy
  • Chemotherapy, Adjuvant
  • Etanercept
  • Humans
  • Immunocompromised Host
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Immunotherapy
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / drug therapy*
  • Mycobacterium marinum
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / microbiology
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Skin / microbiology
  • Skin Diseases, Bacterial / drug therapy*
  • Spondylitis, Ankylosing / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antirheumatic Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Etanercept